NEW DRUG FOR MISMATCH REPAIR DEFICIENT ENDOMETRIAL CANCER AND SOLID TUMORS

被引：0
|
作者：
Aschenbrenner, Diane S. [1 ,2 ]
机构：
[1] Notre Dame Maryland Univ, Baltimore, MD USA
[2] Johns Hopkins Univ, Sch Nursing, Baltimore, MD 21218 USA
来源：
AMERICAN JOURNAL OF NURSING | 2021年 / 121卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R47 [护理学];
学科分类号：
1011 ;
摘要：
引用
收藏
页码：23 / 23
页数：1
相关论文
共 50 条
  • [1] DNA mismatch repair deficient (dMMR) endometrial cancer
    Liu, Chia-Hao
    Yang, Szu-Ting
    Wang, Peng-Hui
    TAIWANESE JOURNAL OF OBSTETRICS & GYNECOLOGY, 2022, 61 (05): : 741 - 743
  • [2] Characteristics of mismatch repair deficient endometrial cancer in a diverse cohort
    Brenner, Sara
    Roecker, Zoe
    Thayer, Elizabeth
    Turashvili, Gulisa
    Modesitt, Susan
    Dilley, Sarah
    GYNECOLOGIC ONCOLOGY, 2024, 190 : S140 - S141
  • [3] Characterization of shared neoantigens landscape in Mismatch Repair Deficient Endometrial Cancer
    De Paolis, Elisa
    Nero, Camilla
    Micarelli, Elisa
    Leoni, Guido
    Piermattei, Alessia
    Trozzi, Rita
    Scarselli, Elisa
    D'Alise, Anna Morena
    Giaco, Luciano
    De Bonis, Maria
    Preziosi, Alessia
    Daniele, Gennaro
    Piana, Diletta
    Pasciuto, Tina
    Zannoni, Gianfranco
    Minucci, Angelo
    Scambia, Giovanni
    Urbani, Andrea
    Fanfani, Francesco
    NPJ PRECISION ONCOLOGY, 2024, 8 (01)
  • [4] Dostarlimab in the treatment of mismatch repair deficient recurrent or advanced endometrial cancer
    Shukla, Siddhant
    Patel, Harsh
    Chen, Shuzhen
    Sun, Rainie
    Wei, Liuya
    Chen, Zhe-Sheng
    CANCER PATHOGENESIS AND THERAPY, 2024, 2 (03): : 135 - 141
  • [5] Neoadjuvant immune checkpoint blockade in mismatch repair deficient endometrial cancer
    De Bruyn, M.
    Eerkens, A. L.
    Brummel, K.
    Vledder, A.
    Paijens, S. T.
    Requesens, M.
    Loiero, D.
    van Rooij, N.
    Plat, A.
    Klok, P.
    Haan, F-J.
    Church, D. N.
    Wardenaar, R.
    Foijer, F.
    Koelzer, V. H.
    Bosse, T.
    Bart, J.
    Jalving, M.
    Reyners, A. K. L.
    Nijman, H. W.
    ANNALS OF ONCOLOGY, 2023, 34 : S508 - S509
  • [6] Mechanisms of mitochondrial dysfunction in development of mismatch repair-deficient endometrial cancer
    Moreno, Diana L.
    Borthwick, Mikayla S.
    Peralta, Leah
    Chan, Wai Kin
    Melendez, Brenda
    Zhang, Qian
    Gokul, Nisha
    Yates, Melinda S.
    CANCER PREVENTION RESEARCH, 2023, 16 (01)
  • [7] Survival of endometrial cancer patients with lymphatic invasion and deficient mismatch repair expression
    Terada, Keith Y.
    Black, Michael
    Terada, Laura H.
    Davis, James
    Shimizu, David M.
    GYNECOLOGIC ONCOLOGY, 2013, 129 (01) : 188 - 192
  • [8] Mismatch repair immunohistochemistry in endometrial cancer: Intact vs. deficient is insufficient
    Riedinger, Courtney
    Esnakula, Ashwini
    Suarez, Adrian
    Chen, Wei
    Cohn, David
    Goodfellow, Paul
    Cosgrove, Casey
    GYNECOLOGIC ONCOLOGY, 2022, 166 : S129 - S129
  • [9] Phase II Study of Avelumab in Patients With Mismatch Repair Deficient and Mismatch Repair Proficient Recurrent/Persistent Endometrial Cancer
    Konstantinopoulos, Panagiotis A.
    Luo, Weixiu
    Liu, Joyce F.
    Gulhan, Doga C.
    Krasner, Carolyn
    Ishizuka, Jeffrey J.
    Gockley, Allison A.
    Buss, Mary
    Growdon, Whitfield B.
    Crowe, Heather
    Campos, Susana
    Lindeman, Neal I.
    Hill, Sarah
    Stover, Elizabeth
    Schumer, Susan
    Wright, Alexi A.
    Curtis, Jennifer
    Quinn, Roxanne
    Whalen, Christin
    Gray, Kathryn P.
    Penson, Richard T.
    Cannistra, Stephen A.
    Fleming, Gini F.
    Matulonis, Ursula A.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (30) : 2786 - +
  • [10] RELEVANT HETEROGENEITY IN MISMATCH REPAIR DEFICIENT TUMORS
    Giner-Calabuig, Mar
    Ukaegbu, Chinedu
    Syngal, Sapna
    Stoffel, Elena M.
    Jover, Rodrigo
    Llor, Xavier
    Xicola, Rosa M.
    GASTROENTEROLOGY, 2020, 158 (06) : S1020 - S1020
12345